Jun 2026 (Q2 FY26) — Aug 6, 2026
PubMatic Q2 FY26 — Double-Digit Revenue Growth Ahead of Schedule Driven by AI and High-Value Formats
Read the full callPubMatic earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 78.6 | +10.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 0.7 | +8.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -1.2 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $8.24 on 15 Oct 2025 → $16.64. High $19.18 (1 Oct 2026), low $6.28 (5 Feb 2026).
Overview
Call summaries
PubMatic Q2 FY26 — Double-Digit Revenue Growth Ahead of Schedule Driven by AI and High-Value Formats
Read the full callEvery analysed call
Financials
Net profit, year on year: +77% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 72 | 86 | 64 | 71 | 68 | 80 | 63 | 79 |
| Operating profit | -1 | 15 | -12 | -5 | -8 | 9 | -15 | 1 |
| Operating margin | −1.9% | 17.3% | −18.6% | −7.7% | −12.4% | 10.7% | −24.4% | 0.7% |
| Profit before tax | -0 | 18 | -11 | -6 | -8 | 10 | -15 | 2 |
| Tax rate | −179.8% | 24.5% | 16.2% | 14.2% | 20.9% | 30.4% | 17.2% | 163.9% |
| Net profit | -1 | 14 | -9 | -5 | -6 | 7 | -13 | -1 |
| EPS ($ per share) | -0.02 | — | -0.20 | -0.11 | -0.14 | — | -0.27 | -0.03 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | 43 | 99 | 128 | 137 | 149 | 135 |
| Total liabilities | — | 196 | 293 | 330 | 399 | 462 | 418 |
| Fixed assets | — | 30 | 50 | 71 | 61 | 59 | 53 |
| Total assets | — | 371 | 550 | 642 | 695 | 740 | 680 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 35 | 24 | 89 | 87 | 81 | 73 | 81 |
| Cash from investing | -22 | -30 | -97 | -81 | -39 | 22 | 6 |
| Cash from financing | -0 | 52 | 9 | 4 | -56 | -73 | -43 |
| Net cash flow | 13 | 47 | 1 | 10 | -14 | — | — |
| Capital expenditure | -10 | -24 | -30 | -36 | -11 | -18 | -14 |
| Free cash flow | 26 | 0 | 58 | 51 | 71 | 56 | 67 |
152 filings between Oct 27, 2025 and Oct 5, 2026.
Purchases
None
No insider bought shares.
Sales
$21.86M
81 sales by 7 insiders
68% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 31 conversions.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Goel Rajeev K. | — | $15.70M | Oct 2, 2026 |
| Pantelick Steven | — | $2.62M | Oct 5, 2026 |
| Woods Andrew | — | $1.20M | Oct 5, 2026 |
| Kumar Mukul | — | $844.9K | Oct 2, 2026 |
| Klimenko Paulina | — | $708.0K | Jul 6, 2026 |
| Goel Amar K. | — | $697.8K | Oct 5, 2026 |
| Gimbel Lisa | — | $96.6K | Oct 1, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Woods Andrew GENERAL COUNSEL & SECRETARY | Sale 10b5-1 plan | 10,079 | $188.0K |
| Oct 5, 2026 | Pantelick Steven CHIEF FINANCIAL OFFICER | Sale 10b5-1 plan | 22,173 | $413.8K |
| Oct 5, 2026 | Goel Amar K. CHAIRMAN, CHIEF INNOVATION OFF | Sale 10b5-1 plan | 10,795 | $201.5K |
| Oct 2, 2026 | Pantelick Steven CHIEF FINANCIAL OFFICER | Sale | 21,398 | $405.0K |
| Oct 2, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Sale | 702 | $13.6K |
| Oct 2, 2026 | Pantelick Steven CHIEF FINANCIAL OFFICER | Sale | 2,093 | $40.7K |
| Oct 2, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Sale | 7,176 | $135.8K |
| Oct 2, 2026 | Goel Amar K. CHAIRMAN, CHIEF INNOVATION OFF | Sale | 651 | $12.6K |
| Oct 2, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale | 45,758 | $866.1K |
| Oct 2, 2026 | Woods Andrew GENERAL COUNSEL & SECRETARY | Sale | 512 | $9.9K |
| Oct 2, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale | 4,475 | $87.0K |
| Oct 2, 2026 | Goel Amar K. CHAIRMAN, CHIEF INNOVATION OFF | Sale | 6,651 | $125.9K |
| Oct 2, 2026 | Woods Andrew GENERAL COUNSEL & SECRETARY | Sale | 5,232 | $99.0K |
| Oct 1, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Option exercise | 97,657 | $0 |
| Oct 1, 2026 | Goel Amar K. CHAIRMAN, CHIEF INNOVATION OFF | Option exercise | 18,097 | $0 |
| Oct 1, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Option exercise | 19,974 | $0 |
| Oct 1, 2026 | Woods Andrew GENERAL COUNSEL & SECRETARY | Option exercise | 15,823 | $0 |
| Oct 1, 2026 | Pantelick Steven CHIEF FINANCIAL OFFICER | Option exercise | 45,664 | $0 |
| Oct 1, 2026 | Gimbel Lisa CHIEF ACCOUNTING OFFICER | Sale 10b5-1 plan | 500 | $9.5K |
| Sep 24, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Conversion 10b5-1 plan | 34,370 | — |
| Sep 24, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 plan | 10,080 | $182.0K |
| Sep 24, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 plan | 40,373 | $748.7K |
| Sep 16, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Conversion 10b5-1 plan | 8,000 | $0 |
| Sep 16, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Sale 10b5-1 plan | 8,000 | $134.2K |
| Sep 3, 2026 | Goel Amar K. CHAIRMAN, CHIEF INNOVATION OFF | Conversion 10b5-1 plan | 6,250 | — |
| Sep 3, 2026 | Goel Amar K. CHAIRMAN, CHIEF INNOVATION OFF | Sale 10b5-1 plan | 6,250 | $106.5K |
| Sep 1, 2026 | Gimbel Lisa CHIEF ACCOUNTING OFFICER | Sale 10b5-1 plan | 500 | $8.2K |
| Aug 20, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Conversion 10b5-1 plan | 34,371 | — |
| Aug 20, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 plan | 49,980 | $824.3K |
| Aug 17, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Sale 10b5-1 plan | 8,000 | $136.4K |
| Aug 17, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Conversion 10b5-1 plan | 8,000 | $0 |
| Aug 15, 2026 | Gimbel Lisa CHIEF ACCOUNTING OFFICER | Option exercise | 801 | $0 |
| Aug 15, 2026 | Gimbel Lisa CHIEF ACCOUNTING OFFICER | Option exercise | 772 | $0 |
| Aug 15, 2026 | Gimbel Lisa CHIEF ACCOUNTING OFFICER | Option exercise | 1,395 | $0 |
| Aug 15, 2026 | Gimbel Lisa CHIEF ACCOUNTING OFFICER | Option exercise | 794 | $0 |
| Aug 13, 2026 | Pantelick Steven CHIEF FINANCIAL OFFICER | Sale 10b5-1 plan | 19,716 | $341.2K |
| Aug 12, 2026 | Gimbel Lisa CHIEF ACCOUNTING OFFICER | Sale 10b5-1 plan | 500 | $8.8K |
| Aug 12, 2026 | Pantelick Steven CHIEF FINANCIAL OFFICER | Sale 10b5-1 plan | 22,203 | $383.1K |
| Aug 10, 2026 | Woods Andrew GENERAL COUNSEL & SECRETARY | Sale 10b5-1 plan | 38,331 | $688.4K |
| Aug 7, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 plan | 211,302 | $3.75M |
| Aug 7, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Conversion 10b5-1 plan | 211,302 | — |
| Jul 23, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 plan | 49,979 | $617.0K |
| Jul 23, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Conversion 10b5-1 plan | 12,500 | — |
| Jul 23, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Conversion 10b5-1 plan | 21,870 | — |
| Jul 16, 2026 | Woods Andrew GENERAL COUNSEL & SECRETARY | Sale 10b5-1 plan | 3,239 | $45.4K |
| Jul 16, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 plan | 8,962 | $125.0K |
| Jul 16, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Conversion 10b5-1 plan | 8,962 | — |
| Jul 16, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Conversion 10b5-1 plan | 8,000 | $0 |
| Jul 16, 2026 | Kumar Mukul PRESIDENT, ENGINEERING | Sale 10b5-1 plan | 8,000 | $109.3K |
| Jul 15, 2026 | Goel Rajeev K. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 plan | 4,060 | $56.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow PubMatic, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading